Skip to main content
. 2018 Feb 12;8:2786. doi: 10.1038/s41598-018-21134-1

Figure 2.

Figure 2

C. crescentus titration. 10,000 TZM-bl cells were incubated for 48 hours with 200TCID50 HIV-189.6 and differing amounts of recombinant C. crescentus (Cc-Control, Cc-Elafin, Cc-BmKn2, Cc-A1AT or Cc-Indo). HIV-1 infection was measured using a β-galactosidase assay. To minimize assay-to-assay variability in OD415 values, the control wells containing HIV-1 + TZM-bl cells with the background of TZM-bl cells subtracted out were set as 100% infection. To obtain the percent infection values for the experimental wells (HIV-1 + TZM-bl cells + Cc-Control or HIV-1 + TZM-bl cells + recombinant C. crescentus) the OD415 values were normalized to the 100% infection (HIV-1 + TZM-bl cells) value. Each experiment was performed in quadruplicate and repeated at least three times.